{{Rsnum
|rsid=1800789
|Gene=FGB
|Chromosome=4
|position=154561591
|Orientation=plus
|GMAF=0.1763
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=FGB
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 1.6 | 41.0 | 57.4
| HCB | 4.9 | 26.8 | 68.3
| JPT | 0.0 | 18.6 | 81.4
| YRI | 0.0 | 19.6 | 80.4
| ASW | 0.0 | 0.0 | 0.0
| CHB | 4.9 | 26.8 | 68.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20031576
|Title=Association of novel genetic Loci with circulating fibrinogen levels: a genome-wide association study in 6 population-based cohorts
|OA=1
}}

{{PMID Auto
|PMID=20167083
|Title=Fibrinogen beta variants confer protection against coronary artery disease in a Greek case-control study
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1800789
|overall_frequency_n=16
|overall_frequency_d=128
|overall_frequency=0.125
|n_genomes=12
|n_genomes_annotated=0
|n_haplomes=13
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}